SCP
TMO icon

Shorepoint Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Shorepoint Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$6.41M Buy
+13,224
New +$6.16M 1.28% 28
2025
Q1 		$6.72M Buy
13,508
+60
+0.4% +$32.5K 1.52% 19
2024
Q4 		$7M Buy
13,448
+542
+4% +$298K 1.6% 18
2024
Q3 		$7.98M Buy
12,906
+117
+0.9% +$69.3K 1.82% 14
2024
Q2 		$7.07M Buy
12,789
+144
+1% +$82.5K 1.66% 17
2024
Q1 		$7.35M Sell
12,645
-618
-5% -$347K 1.8% 14
2023
Q4 		$7.04M Sell
13,263
-563
-4% -$273K 1.89% 14
2023
Q3 		$7M Sell
13,826
-616
-4% -$328K 2.05% 12
2023
Q2 		$7.54M Sell
14,442
-113
-0.8% -$61K 2.12% 12
2023
Q1 		$8.39M Buy
14,555
+690
+5% +$389K 2.4% 7
2022
Q4 		$7.63M Buy
13,865
+10,705
+339% +$5.67M 2.12% 9
2022
Q3 		$1.6M Buy
3,160
+32
+1% +$17.9K 0.76% 46
2022
Q2 		$1.7M Sell
3,128
-40
-1% -$22K 0.72% 52
2022
Q1 		$1.87M Buy
3,168
+49
+2% +$28.1K 0.78% 45
2021
Q4 		$2.08M Sell
3,119
-414
-12% -$258K 0.84% 46
2021
Q3 		$2.02M Buy
+3,533
New +$1.94M 0.91% 45
2021
Q1 		$1.62M Sell
3,549
-415
-10% -$198K 0.87% 44
2020
Q4 		$1.85M Sell
3,964
-104
-3% -$48.8K 1.02% 42
2020
Q3 		$1.8M Sell
4,068
-47
-1% -$19.4K 1.12% 38
2020
Q2 		$1.49M Sell
4,115
-669
-14% -$224K 0.97% 42
2020
Q1 		$1.36M Buy
4,784
+62
+1% +$19.6K 1.09% 36
2019
Q4 		$1.53M Sell
4,722
-558
-11% -$169K 0.88% 48
2019
Q3 		$1.54M Sell
5,280
-80
-1% -$22.9K 0.91% 46
2019
Q2 		$1.57M Sell
5,360
-765
-12% -$211K 0.9% 46
2019
Q1 		$1.68M Buy
+6,125
New +$1.52M 0.95% 45

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Shorepoint Capital Partners's TMO Position: Q3 2025 in Review

Shorepoint Capital Partners opened a new position in Thermo Fisher Scientific (TMO) in Q3 2025: 13,224 shares worth $6.41M. The stake represents 1.28% of the portfolio and ranks #28 among its holdings. This is a return to the name: Shorepoint Capital Partners previously reported a position in TMO as recently as Q1 2025.

Shorepoint Capital Partners first reported a position in TMO in Q1 2019 and has held it in 25 quarters since. The position peaked at $8.39M in Q1 2023. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Shorepoint Capital Partners held 13,224 shares of Thermo Fisher Scientific worth $6.41M as of Q3 2025.
  • Thermo Fisher Scientific was a new Shorepoint Capital Partners position in Q3 2025.
  • Thermo Fisher Scientific made up 1.28% of Shorepoint Capital Partners's portfolio in Q3 2025, its #28 holding.
  • Shorepoint Capital Partners first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 25 quarters since.
  • Shorepoint Capital Partners's Thermo Fisher Scientific position peaked at $8.39M in Q1 2023.
  • 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Shorepoint Capital Partners's 13F filing for Q3 2025, filed 3 Oct 2025.